Alembic Pharmaceuticals informs about company updates

21 Jan 2020 Evaluate

Alembic Pharmaceuticals has informed that the US Food and Drug Administration (USFDA) has conducted an inspection at the company’s API Facility located at Karkhadi from 13th January, 2020 to 17th January, 2020. This was a scheduled pre-approval inspection and at the end of the inspection, the USFDA issued a Form 483 with two observations. 

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

899.90 -2.30 (-0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×